Science

Dr Reddy’s launches Lansoprazole DR orally disintegrating tablets in US

Our Bureau Hyderabad | Updated on February 22, 2021

It’s the therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets

Dr Reddy’s Laboratories Ltd has announced the launch of Lansoprazole DR orally disintegrating tablets, a therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets, 15 mg and 30 mg, approved by the US Food and Drug Administration (USFDA).

Also read: Dr Reddy’s Labs launches Capecitabine tablets in US market

The Prevacid brand and generic had US sales of approximately $87 million MAT for the most recent 12 months ending in December 2020, according to IMS Health.

Dr Reddy’s Lansoprazole DR orally disintegrating tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10), according to a statement.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on February 22, 2021
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.